Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Icahn School of Medicine at Mount Sinai
AddedFeb 15, 2024
UpdatedJun 28, 2026
Icahn School of Medicine at Mount Sinai

Icahn School of Medicine at Mount Sinai

ISMMS: A premier private medical school in NYC, integral to the Mount Sinai Health System.

HQ
New York City, NY, US
Founded
1963
Overview
Compare
Fundraising
Employees
Website

The Icahn School of Medicine at Mount Sinai (ISMMS), established in New York City, is a premier private medical school that serves as the academic teaching arm of the Mount Sinai Health System. The institution's core mission is to advance medical education, research, and clinical care. ISMMS offers a range of programs including MD, PhD, and dual-degree options, focusing on innovative biomedical research and patient-centered healthcare. The school is dedicated to training the next generation of medical professionals and researchers, with a strong emphasis on addressing complex health issues and improving patient outcomes.

Notable affiliated individuals include renowned researchers and clinicians who contribute significantly to various fields of medicine. The school has received substantial support from prominent investors and philanthropists, such as Carl Icahn, after whom the institution is named. ISMMS has achieved significant milestones in medical research, particularly in genomics, cancer, and neuroscience. Its impact is evident through its contributions to groundbreaking medical discoveries and its role in shaping modern healthcare practices.

Similar Companies

NYU Grossman School of Medicine logo

NYU Grossman School of Medicine

med.nyu.edu

Yale School of Medicine logo

Yale School of Medicine

medicine.yale.edu

Harvard Medical School logo

Harvard Medical School

hms.harvard.edu

Boston University School of Medicine logo

Boston University School of Medicine

NYU Langone Health logo

NYU Langone Health

nyulangone.org

Washington University School of Medicine logo

Washington University School of Medicine

medicine.wustl.edu

Perelman School of Medicine logo

Perelman School of Medicine

Wake Forest School of Medicine logo

Wake Forest School of Medicine

Medical College of Wisconsin logo

Medical College of Wisconsin

mcw.edu

Rush Medical College logo

Rush Medical College

rushu.rush.edu

University of Colorado Anschutz Medical Campus logo

University of Colorado Anschutz Medical Campus

cuanschutz.edu

Baylor College of Medicine logo

Baylor College of Medicine

bcm.edu

Hospital for Special Surgery logo

Hospital for Special Surgery

hss.edu

Cedars-Sinai logo

Cedars-Sinai

University of Maryland logo

University of Maryland

umaryland.edu

Icahn School of Medicine at Mount Sinai - Quick Facts

Who are Icahn School of Medicine at Mount Sinai's competitors?

Companies similar to Icahn School of Medicine at Mount Sinai include NYU Grossman School of Medicine, Yale School of Medicine, Harvard Medical School and Boston University School of Medicine.

When was Icahn School of Medicine at Mount Sinai founded?

Icahn School of Medicine at Mount Sinai was founded in 1963.

Where is Icahn School of Medicine at Mount Sinai's headquarters located?

Icahn School of Medicine at Mount Sinai's headquarters is located in New York City, NY, US.

When was Icahn School of Medicine at Mount Sinai's last funding round?

Icahn School of Medicine at Mount Sinai's most recent funding round was for $4M (USD) in January 2024.

How much has Icahn School of Medicine at Mount Sinai raised to-date?

As of Jan 25, 2024, Icahn School of Medicine at Mount Sinai has raised a total of $11.3M (USD).

How many employees does Icahn School of Medicine at Mount Sinai have?

Icahn School of Medicine at Mount Sinai has 3,770 employees as of Feb 4, 2024.

Classification

Industry
  • Professional Service Companies
Technology
  • HealthTech
Geographic Exposure
  • United States
Main Product
  • Medical Education
Tags
  • Consulting
  • Education
NAICS
  • 610000Educational Services
  • 611300Colleges, Universities, and Professional Schools
  • 611310Colleges, Universities, and Professional Schools
  • 611000Educational Services
SIC
  • 8220Colleges, Universities, Professional Schools, And Junior Colleges
  • 8221Colleges, Universities, And Professional Schools
  • 8200Educational Services
Show 9 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 620000Health Care and Social Assistance
SIC
  • 8060Hospitals
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8290Schools And Educational Services, Not Elsewhere Classified
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified